Inability of methylphenidate or mazindol to prevent the lowering of 3,4-dihydroxyphenylacetic acid in rat brain by amphetamine
- 1 September 1979
- journal article
- letter
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 31 (1), 183-184
- https://doi.org/10.1111/j.2042-7158.1979.tb13468.x
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Antagonism by methylphenidate of the stereotyped behaviour produced by (+)-amphetamine in reserpinized ratsJournal of Pharmacy and Pharmacology, 1978
- Inhibition of mouse brain monoamine oxidase by (+)-amphetamine in vivoJournal of Pharmacy and Pharmacology, 1978
- Biochemical differentiation of amphetamine vs methylphenidate and nomifensine in ratsJournal of Pharmacy and Pharmacology, 1977
- RELEASE OF ENDOGENOUS NOREPINEPHRINE AND DOPAMINE FROM CEREBRAL-CORTEX BY AMPHETAMINE1977
- Elevation of 3, 4-dihydroxyphenylacetic acid concentrations in rat brain and stimulation of prolactin secretion by fenfluramine: evidence for antagonism at dopamine receptor sitesJournal of Pharmacy and Pharmacology, 1976
- MOLECULAR-GEOMETRY OF INHIBITORS OF UPTAKE OF CATECHOLAMINES AND SEROTONIN IN SYNAPTOSOMAL PREPARATIONS OF RAT-BRAIN1976
- Mechanism of efflux of noradrenaline from adrenergic nerves in rabbit atriaBritish Journal of Pharmacology, 1973
- 3,4‐Dihydroxyphenylacetic acid and 4‐hydroxy‐3‐methoxyphenylacetic acid in the mouse striatum: a reflection of intra‐ and extra‐neuronal metabolism of dopamine?British Journal of Pharmacology, 1971
- Procedure for the simultaneous determination of dopamine, 3-methoxy-4-hydroxyphenylacetic acid, and 3,4-dihydroxyphenylacetic acid in brainAnalytical Biochemistry, 1971
- The effect of tropolone on the formation of 3,4‐dihydroxyphenylacetic acid and 4‐hydroxy‐3‐methoxyphenylacetic acid in the brain of the mouseBritish Journal of Pharmacology, 1969